Sabra Healthcare REIT SBRA
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Sabra Healthcare REIT (SBRA) Core Market Data and Business Metrics
Latest Closing Price
$17.36Price-Earnings Ratio
41.33Total Outstanding Shares
237.91 Million SharesDividend
$0.30 Per Share QuarterlySIC Description
Real Estate Investment TrustsPrimary Exchange
NASDAQHeadquarters
18500 Von Karman, Irvine, CA, 92612
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 2,451,969 Shares | 7.42 | 3/14/2025 | 18,190,094 Shares |
| 2,354,896 Shares | 7.24 | 2/28/2025 | 17,045,198 Shares |
| 2,615,304 Shares | 7.83 | 2/14/2025 | 20,468,252 Shares |
| 1,494,716 Shares | 11.85 | 1/31/2025 | 17,719,674 Shares |
| 1,834,166 Shares | 9.76 | 1/15/2025 | 17,893,204 Shares |
| 2,159,079 Shares | 8.3 | 12/31/2024 | 17,927,550 Shares |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $-89.96 Million |
| Net Cash Flow | $30.12 Million |
| Net Cash Flow From Financing Activities | $-89.96 Million |
| Net Cash Flow, Continuing | $30.01 Million |
| Net Cash Flow From Investing Activities | $-189.34 Million |
| Net Cash Flow From Operating Activities, Continuing | $309.31 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss | $97.17 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Net Income/Loss Attributable To Parent | $97.17 Million |
| Diluted Average Shares | $472.22 Million |
| Diluted Earnings Per Share | $0.42 |
| Costs And Expenses | $584.93 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $74.44 Million |
| Comprehensive Income/Loss Attributable To Parent | $74.44 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $-22.73 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Equity | $2.74 Billion |
| Equity Attributable To Noncontrolling Interest | $0 |
| Noncurrent Assets | $0 |
| Current Assets | $5.37 Billion |
| Equity Attributable To Parent | $2.74 Billion |
| Long-term Debt | $2.47 Billion |
Historical Dividends
Current dividend: $0.30 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 3, 2025 | Feb 28, 2025 | Feb 14, 2025 | $0.3 | Quarterly |
| Oct 31, 2024 | Nov 29, 2024 | Nov 15, 2024 | $0.3 | Quarterly |
| Aug 7, 2024 | Aug 30, 2024 | Aug 19, 2024 | $0.3 | Quarterly |
| May 8, 2024 | May 31, 2024 | May 20, 2024 | $0.3 | Quarterly |
| Feb 1, 2024 | Feb 29, 2024 | Feb 13, 2024 | $0.3 | Quarterly |
| Nov 6, 2023 | Nov 30, 2023 | Nov 17, 2023 | $0.3 | Quarterly |